Medicare Enrolled
Dr. Bassam Alzagatiti, M.D.
Optician · Visalia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alzagatiti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alzagatiti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alzagatiti
Dr. Bassam Alzagatiti is an optician specialist in Visalia, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Alzagatiti performed 544 Medicare services across 438 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alzagatiti received a total of $10,132 from 59 pharmaceutical and/or device companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alzagatiti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 544 Medicare services
$10,132 industry payments
Medicare Practice Summary
Medicare Utilization ↗544
Medicare services
Bottom 33% in CA for optician
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
438
Unique beneficiaries
$77
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~29 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
148 | $47 | $189 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
130 | $87 | $278 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
92 | $118 | $426 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
53 | $71 | $247 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
37 | $59 | $190 |
| Neurobehavioral status exam, first hour A clinical assessment of neurobehavioral status lasting one hour. This evaluation examines mental and behavioral functions. |
34 | $64 | $255 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $97 | $362 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
16 | $37 | $110 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
14 | $157 | $580 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,132
Total received (2018-2024)
Avg $1,447/year across 7 years
Top 14% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
575
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,102 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,525
2023
$2,555
2022
$331
2021
$820
2020
$823
2019
$827
2018
$1,251
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$647
ABBVIE INC.
$428
Novartis Pharmaceuticals Corporation
$215
ARGENX US, INC.
$195
Neurelis, Inc.
$193
PFIZER INC.
$189
Alexion Pharmaceuticals, Inc.
$165
ACADIA Pharmaceuticals Inc
$142
Neurocrine Biosciences, Inc.
$120
SK Life Science, Inc.
$118
Teva Pharmaceuticals USA, Inc.
$103
Lundbeck LLC
$98
LivaNova USA, Inc.
$85
JAZZ PHARMACEUTICALS INC.
$80
Lilly USA, LLC
$74
Celgene Corporation
$74
Kyowa Kirin, Inc.
$71
CATALYST PHARMACEUTICALS, INC.
$68
CSL Behring
$63
EMD Serono, Inc.
$59
AstraZeneca Pharmaceuticals LP
$50
Sumitomo Pharma America, Inc.
$45
Biogen, Inc.
$40
Genentech USA, Inc.
$38
TG Therapeutics, Inc.
$30
Otsuka America Pharmaceutical, Inc.
$27
Medtronic, Inc.
$25
Takeda Pharmaceuticals U.S.A., Inc.
$25
Averitas Pharma Inc.
$23
Eisai Inc.
$23
Cycle Pharmaceuticals Inc
$10
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
UCB, Inc.
$1,540
Novartis Pharmaceuticals Corporation
$621
Biogen, Inc.
$598
Supernus Pharmaceuticals, Inc.
$522
ABBVIE INC.
$491
Lilly USA, LLC
$403
Teva Pharmaceuticals USA, Inc.
$365
AbbVie Inc.
$365
Neurelis, Inc.
$352
EMD Serono, Inc.
$269
ARGENX US, INC.
$267
Amgen Inc.
$265
Lundbeck LLC
$264
Alexion Pharmaceuticals, Inc.
$256
PFIZER INC.
$223
Allergan, Inc.
$213
SK Life Science, Inc.
$210
ACADIA Pharmaceuticals Inc
$208
Celgene Corporation
$186
Kyowa Kirin, Inc.
$176
Adamas Pharmaceuticals, Inc.
$174
Sumitomo Pharma America, Inc.
$146
Sunovion Pharmaceuticals Inc.
$143
Genentech USA, Inc.
$128
Neurocrine Biosciences, Inc.
$120
AstraZeneca Pharmaceuticals LP
$120
Allergan Inc.
$116
Otsuka America Pharmaceutical, Inc.
$114
GENZYME CORPORATION
$113
LivaNova USA, Inc.
$112
Eisai Inc.
$101
CSL Behring
$98
JAZZ PHARMACEUTICALS INC.
$80
CATALYST PHARMACEUTICALS, INC.
$68
E.R. Squibb & Sons, L.L.C.
$62
Takeda Pharmaceuticals U.S.A., Inc.
$49
Amneal Pharmaceuticals LLC
$49
Grifols USA, LLC
$47
US WorldMeds, LLC
$44
NOVARTIS PHARMACEUTICALS CORPORATION
$42
TG Therapeutics, Inc.
$30
Acorda Therapeutics, Inc
$30
ARBOR PHARMACEUTICALS, INC.
$30
Mallinckrodt Hospital Products Inc.
$29
Medtronic, Inc.
$25
TG THERAPEUTICS, INC.
$24
Avanir Pharmaceuticals, Inc.
$24
Catalyst Pharmaceuticals, Inc.
$24
Amylyx Pharmaceuticals, Inc.
$24
Averitas Pharma Inc.
$23
Janssen Pharmaceuticals, Inc
$23
Bayer HealthCare Pharmaceuticals Inc.
$21
Upsher-Smith Laboratories LLC
$18
BANNER LIFE SCIENCES, LLC
$18
Arbor Pharmaceuticals, Inc.
$17
Biohaven Pharmaceuticals, Inc.
$15
Sandoz Inc.
$15
Corium, LLC
$13
Cycle Pharmaceuticals Inc
$10
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APOKYN · APTIOM · AUBAGIO · AUSTEDO · Adlarity · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BRILINTA · BRIUMVI · Betaseron · Briviact · DUOPA · EMGALITY · EPIDIOLEX · FIRDAPSE · FYCOMPA · Fintepla · GILENYA · GOCOVRI · Gamunex-C · HYQVIA · Hizentra · Horizant · INGREZZA · INTELLIS ADAPTIVESTIM · KESIMPTA · KISUNLA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · Mavenclad · NAMZARIC · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OXTELLAR XR · Ocrevus · Ocrevus Zunovo · PANZYGA · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · RELYVRIO · REXULTI · RYTARY · Rebif · Rystiggo · SKYCLARYS · SOLIRIS · TECFIDERA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · UBRELVY · ULTOMIRIS · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · WAINUA · Xadago · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
43
Per 100K population
9.0
County median income
$69,489
Nearest hospital
KAWEAH HEALTH MEDICAL CENTER
6.2 mi
6.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alzagatiti is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 14% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alzagatiti experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Alzagatiti performed 148 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alzagatiti receive payments from pharmaceutical companies?
Yes. Dr. Alzagatiti received a total of $10,132 from 59 companies across 575 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alzagatiti's costs compare to other opticians in Visalia?
Dr. Alzagatiti's average Medicare payment per service is $77. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alzagatiti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Visalia
Browse opticians in Visalia ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology